Skip to content
Screener

Tempus AI, Inc. TEM Free cash flow

Free cash flow at other companies

NeoGenomics logo
NeoGenomicsNEO
-$13.14M+56.0%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
-$1.76M+73.4%
IQVIA logo
IQVIAIQV
$360M+23.3%
Guardant Health logo
Guardant HealthGH
-$71.2M-6.0%
Natera, Inc. logo
Natera, Inc.NTRA
$18.03M-20.3%
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
$1.9M+121%

Other financials

Income statement

See full
Revenue$382.5M+21.6%
Operating income-$75.9M-22.9%
Net income$5.6M+113%
EPS (diluted)$0.03+112%

Balance sheet

See full
Cash & equivalents$599.6M+219%
Total debt$83.5M+51.1%
Total equity$444.9M+43.7%
Total assets$2.4B+45.6%

Cash flow

See full
Operating cash flow-$7.5M—
CapEx-$22.5M-400%

Valuation

See full
Market cap$8.43B-12.3%
Enterprise value$7.91B-16.6%
P/S5.9×-4.2×

Profitability

See full
Operating margin-19.8%-3.3pp
Net margin-17.8%-2.4pp
FCF margin-19.5%—

Returns & leverage

See full
Return on equity-67.4%-16.0pp
Debt / equity0.2×0.0×
Current ratio3.3×+1.8×

Where this comes from

Calculated from Tempus AI, Inc.’s reported figures.

−$7.5Mnet cash from operating+$22.5Mcapital expenditures=-$30.05M

The source filing: Tempus AI, Inc.’s 8-K, filed July 30, 2026. Open the filing →

Filed
Jul 30, 2026, 4:01 PM EDT
Accession
0001193125-26-326083

FAQ

What is Tempus AI, Inc.'s free cash flow?
Tempus AI, Inc. (TEM) reported free cash flow of -$30.05M in Q2 2026.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.

Ask your AI about Tempus AI, Inc.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude